Delivery Order SPE2DB20D1100-SPE2DB24FC5X9
Award Date
7/5/24
Potential Completion Date
7/26/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.54 firm fixed-price delivery order is for the supply of the pharmaceutical product HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $9,940.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a period of performance through September 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.54 firm fixed-price delivery order is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a medication. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for $2,485.20 to provide a pharmaceutical product called HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,526.54, is for the delivery of the pharmaceutical product HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract is a Firm Fixed Price Delivery Order with a completion date of January 28, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp has an...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,656.80 firm fixed price contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has a completion date of May 8, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of Hemangeol 4.28 mg/ml oral solution in 120 ml bottles. The $1,242.60 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 9, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous indefinite delivery contracts...
This federal contract award was made to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,485.20 firm fixed-price delivery order is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a specialty medication. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen is a significant supplier of pharmaceutical and medical products to various government...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a ceiling value of $2,526.54 and a period of performance ending on March 17, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has a ceiling value of $1,656.80 and an ultimate completion date of September 3, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...